Intel's Stock Hits a New All-Time High: Is It Still a Buy?

Intel's Q1 revenue rose 7% to $13.6 billion, while its foundry revenue increased 16%, helping fuel a sharp stock rally this year. However, foundry losses still widened slightly to $2.4 billion from $2.3 billion a year ago, and the shares now trade at a steep 125x forward earnings. The article is constructive on AI-driven demand and foundry growth, but it cautions that the valuation already prices in substantial execution improvement.

Analysis

The market is no longer pricing Intel as a cyclical turnaround; it is pricing a successful industrial policy + AI infrastructure option. That matters because the main second-order winner is not INTC alone, but the broader “domestic fab ecosystem” trade: equipment, materials, and specialized EDA/IP names should continue to absorb incremental capex expectations even if Intel’s own economics lag for another 4-8 quarters. At the same time, Intel’s rising foundry activity creates a competitive overhang for Asian contract manufacturers and any merchant foundry supplier that relies on process-node leadership as a moat.

The bigger risk is that the valuation has outrun the cadence of fundamental proof. Foundry revenue growth can keep surprising for several quarters while cumulative losses still widen, which is exactly the setup that tends to break late-cycle momentum trades: the stock is now sensitive less to operating data than to any sign of slower customer wins, delayed node qualification, or capex intensity compressing future margins. In other words, the path to upside has to remain a “beats + credibility” story for at least two more reporting cycles; one miss could trigger a sharp de-rating because the multiple already assumes normalization that hasn’t arrived.

Consensus may be missing that Intel’s foundry progress is not automatically additive to equity value if it cannibalizes capital efficiency elsewhere in the business. The more successful the buildout, the more investors should worry about a multi-year period where revenue grows but free cash flow remains mediocre, which could cap the stock even in a bullish AI tape. That creates a cleaner relative-value expression in semicap and AI infrastructure, where spend is monetized immediately rather than deferred into a low-visibility turnaround.

For NVDA, the indirect implication is mixed: any credible second source of advanced capacity is positive for long-term supply resilience, but near term it can modestly dampen scarcity optics that supported premium multiples. For NDAQ and NFLX, the direct read-through is minimal; the only real effect is sentiment spillover into tech multiples more broadly if INTC keeps re-rating, which can transiently lift beta but won’t change fundamentals.

Key Decisions for Investors

• Fade the momentum: initiate a small tactical short INTC via call overwrites or put spreads into the next earnings window, targeting a 6-10 week horizon; risk/reward favors downside if the market gets a single sign of slower foundry conversion or weaker margin guidance.
• Relative-value long semicap basket vs short INTC: long AMAT/LRCX/KLAC or SOXX, short INTC for 3-6 months; if Intel capex continues, the spend accrues to suppliers first while Intel remains stuck with low cash conversion.
• If long INTC for strategic reasons, hedge with OTM puts 1-2 quarters out; the stock is now more vulnerable to multiple compression than to operating misses, so convex protection is preferable to tight stops.
• Use any further INTC strength to reduce exposure and rotate into NVDA on dips; NVDA retains the better monetization path from AI capex, while INTC still carries execution risk and balance-sheet drag.
• Avoid chasing INTC above current levels unless the next two reports show both sustained foundry revenue acceleration and narrowing foundry losses; absent that, the trade is a crowded turnaround with asymmetric disappointment risk.